We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+10.54%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.7B
AUM Growth
+$567M
(+2.6%)
Cap. Flow
-$1.43B
Cap. Flow
% of AUM
-6.31%
Top 10 Holdings %
Top 10 Hldgs %
30.36%
Holding
1,757
New
185
Increased
417
Reduced
837
Closed
239
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Everest Group
EG
|
+$100M |
| 2 |
Take-Two Interactive
TTWO
|
+$82.9M |
| 3 |
United Parcel Service
UPS
|
+$82.8M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$67.7M |
| 5 |
EA
Electronic Arts
EA
|
+$66.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$166M |
| 2 |
HCA Healthcare
HCA
|
+$101M |
| 3 |
Alibaba
BABA
|
+$82.1M |
| 4 |
Monster Beverage
MNST
|
+$76.7M |
| 5 |
ResMed
RMD
|
+$70.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.12% |
| 2 | Consumer Discretionary | 14.12% |
| 3 | Communication Services | 13.21% |
| 4 | Financials | 12.25% |
| 5 | Healthcare | 11.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
STAAR Surgical
STAA
$1.26B
| $904K | ﹤0.01% |
+5,930
| New | +$781K |
|
|
DVAX
902
DELISTED
Dynavax Technologies
DVAX
| $900K | ﹤0.01% |
91,345
-45,489
| -33% | -$414K |
|
903
Varonis Systems
VRNS
$5.26B
| $899K | ﹤0.01% |
15,610
-800
| -5% | -$41.6K |
|
904
Cooper Companies
COO
$14.9B
| $896K | ﹤0.01% |
+9,040
| New | +$886K |
|
|
FRGI
905
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $895K | ﹤0.01% |
66,652
+23,403
| +54% | +$319K |
|
906
Amneal Pharmaceuticals
AMRX
$6.02B
| $893K | ﹤0.01% |
174,420
+115,870
| +198% | +$659K |
|
907
Kosmos Energy
KOS
$1.51B
| $889K | ﹤0.01% |
+256,830
| New | +$796K |
|
908
Biglari Holdings Class B
BH
$1.22B
| $886K | ﹤0.01% |
5,557
+2,620
| +89% | +$403K |
|
|
ICPT
909
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $884K | ﹤0.01% |
44,259
+16,506
| +59% | +$327K |
|
910
AeroVironment
AVAV
$9.59B
| $881K | ﹤0.01% |
8,795
-2,230
| -20% | -$245K |
|
911
Pulmonx
LUNG
$92.8M
| $878K | ﹤0.01% |
19,899
-1,260
| -6% | -$54.9K |
|
912
Iron Mountain
IRM
$37.7B
| $877K | ﹤0.01% |
20,713
-58,540
| -74% | -$2.46M |
|
913
Ranpak Holdings
PACK
$479M
| $877K | ﹤0.01% |
35,050
-2,820
| -7% | -$59.2K |
|
|
TPTX
914
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $874K | ﹤0.01% |
11,202
+317
| +3% | +$23.4K |
|
|
GBIO
915
DELISTED
Generation Bio
GBIO
| $873K | ﹤0.01% |
3,244
-35
| -1% | -$10.5K |
|
916
Cogent Communications
CCOI
$530M
| $872K | ﹤0.01% |
11,335
-1,177
| -9% | -$87.4K |
|
917
Cars.com
CARS
$672M
| $871K | ﹤0.01% |
60,795
-4,820
| -7% | -$66.9K |
|
|
EVRI
918
DELISTED
Everi Holdings
EVRI
| $871K | ﹤0.01% |
+34,910
| New | +$659K |
|
919
Mercury Systems
MRCY
$6.59B
| $868K | ﹤0.01% |
13,098
-45,936
| -78% | -$3.17M |
|
920
NWPX Infrastructure Inc
NWPX
$1.11B
| $865K | ﹤0.01% |
30,613
-1,830
| -6% | -$58.1K |
|
921
Teladoc Health
TDOC
$1.26B
| $862K | ﹤0.01% |
5,185
-2,316
| -31% | -$375K |
|
|
ANAT
922
DELISTED
American National Group, Inc. Common Stock
ANAT
| $860K | ﹤0.01% |
5,788
-820
| -12% | -$110K |
|
923
Ecolab
ECL
$77.4B
| $857K | ﹤0.01% |
4,162
-3,302
| -44% | -$718K |
|
924
Progyny
PGNY
$1.99B
| $856K | ﹤0.01% |
14,505
-3,400
| -19% | -$191K |
|
925
EastGroup Properties
EGP
$11B
| $850K | ﹤0.01% |
5,171
-6,363
| -55% | -$1.01M |
|
Similar funds
FDCDDQ
WP
N
PCH
Los Angeles Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Los Angeles Capital Management held 1,757 positions worth $22.7B, up 2.6% from $22.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Los Angeles Capital Management withdrew a net $1.43B in Q2 2021, closing 239 positions and reducing 837 holdings. Its most notable exit was Alibaba, an estimated $82.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Los Angeles Capital Management opened a new position in Ulta Beauty worth $35.5M.
- Los Angeles Capital Management's largest Q2 2021 buy was Ulta Beauty: 102,538 shares worth $35.5M.
- Los Angeles Capital Management added most to Everest Group in Q2 2021, an estimated $100M increase.
- Los Angeles Capital Management's biggest Q2 2021 reduction was Procter & Gamble, cutting an estimated $166M.
- Los Angeles Capital Management fully exited Alibaba in Q2 2021, selling an estimated $82.1M.
- Los Angeles Capital Management's ten largest holdings make up 30% of its $22.7B portfolio in Q2 2021.
- Los Angeles Capital Management opened 185 new positions and closed 239 in Q2 2021.
- Los Angeles Capital Management's portfolio value rose 2.6% quarter-over-quarter to $22.7B.
Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.